PCN Insights, News, Videos, and More
Videos
07/09/2024
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders .
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders .
Craig Chepke, MD, DFAPA, shares...
07/09/2024
Psych Congress Network
News
07/08/2024
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of...
07/08/2024
Psych Congress Network
Videos
07/02/2024
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders such as drug-induced Parkinsonism.
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders such as drug-induced Parkinsonism.
Craig Chepke, MD, DFAPA, shares...
07/02/2024
Psych Congress Network
News
07/02/2024
AKL-T01 is indicated for adults with primarily inattentive or combined-type ADHD who have a demonstrated attention issue.
AKL-T01 is indicated for adults with primarily inattentive or combined-type ADHD who have a demonstrated attention issue.
AKL-T01 is indicated for adults...
07/02/2024
Psych Congress Network
Videos
07/02/2024
Learn about the safety and efficacy of these new agents and gain insights into improving diagnosis and treatment strategies.
Learn about the safety and efficacy of these new agents and gain insights into improving diagnosis and treatment strategies.
Learn about the safety and...
07/02/2024
Psych Congress Network
Videos
07/01/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
07/01/2024
Psych Congress Network
Q&As
07/01/2024
Nishi Bhopal, MD, explains how to maintain professionalism while using social media to promote one'e telehealth practice.
Nishi Bhopal, MD, explains how to maintain professionalism while using social media to promote one'e telehealth practice.
Nishi Bhopal, MD, explains how...
07/01/2024
Psych Congress Network
SPONSORED VIDEO
06/28/2024
Listen to Megan, an adult with ADHD, and her best friend talk about her ADHD journey, including current treatment with a nonstimulant medication.
Listen to Megan, an adult with ADHD, and her best friend talk about her ADHD journey, including current treatment with a nonstimulant medication.
Listen to Megan, an adult with...
06/28/2024
Psych Congress Network
News
06/27/2024
Cannabis use was significantly associated with psychotic disorders during adolescence, but not during young adulthood, according to results from an observational study published in Psychological Medicine.
Cannabis use was significantly associated with psychotic disorders during adolescence, but not during young adulthood, according to results from an observational study published in Psychological Medicine.
Cannabis use was significantly...
06/27/2024
Psych Congress Network
